APG Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.1M Buy
921,755
+244,227
+36% +$19.7M 0.15% 125
2026
Q1
$51M Sell
677,528
-61,212
-8% -$5.86M 0.16% 111
2025
Q4
$60.4M Sell
738,740
-48,981
-6% -$4.76M 0.17% 101
2025
Q3
$63.8M Buy
787,721
+6,300
+0.8% +$579K 0.18% 104
2025
Q2
$58M Buy
781,421
+79,921
+11% +$6.78M 0.17% 114
2025
Q1
$58.4M Sell
701,500
-4,000
-0.6% -$358K 0.18% 104
2024
Q4
$54.4M Buy
+705,500
New +$61.1M 0.15% 115
2024
Q3
Sell
-1,236,283
Closed -$90.8M 555
2024
Q2
$90.8M Sell
1,236,283
-307,230
-20% -$25.2M 0.16% 137
2024
Q1
$125M Buy
1,543,513
+45,015
+3% +$3.84M 0.22% 112
2023
Q4
$112M Buy
1,498,498
+127,387
+9% +$9.71M 0.22% 112
2023
Q3
$107M Sell
1,371,111
-278,019
-17% -$23.3M 0.22% 110
2023
Q2
$133M Sell
1,649,130
-196,164
-11% -$16.9M 0.27% 87
2023
Q1
$137M Sell
1,845,294
-81,411
-4% -$6.64M 0.29% 86
2022
Q4
$150M Buy
1,926,705
+1,217,382
+172% +$98.7M 0.28% 87
2022
Q3
$58.5M Sell
709,323
-184,873
-21% -$16.6M 0.15% 156
2022
Q2
$76.8M Sell
894,196
-56,808
-6% -$5.76M 0.18% 150
2022
Q1
$94.8M Sell
951,004
-135,535
-12% -$14.3M 0.18% 140
2021
Q4
$98.8M Sell
1,086,539
-131,683
-11% -$15.2M 0.17% 153
2021
Q3
$132M Sell
1,218,222
-5,500
-0.4% -$712K 0.23% 113
2021
Q2
$128M Sell
1,223,722
-157,285
-11% -$19.7M 0.22% 121
2021
Q1
$139M Sell
1,381,007
-491,117
-26% -$57.6M 0.24% 109
2020
Q4
$179M Buy
1,872,124
+177,511
+10% +$19.5M 0.29% 80
2020
Q3
$150M Sell
1,694,613
-250,077
-13% -$25.1M 0.26% 98
2020
Q2
$159M Sell
1,944,690
-157,175
-7% -$15.1M 0.29% 91
2020
Q1
$190M Buy
2,101,865
+1,137,886
+118% +$121M 0.37% 64
2019
Q4
$97.4M Buy
963,979
+468,700
+95% +$51.4M 0.16% 167
2019
Q3
$49.3M Sell
495,279
-67,341
-12% -$7.03M 0.08% 276
2019
Q2
$48.1M Buy
562,620
+80,200
+17% +$7.32M 0.08% 266
2019
Q1
$39.1M Sell
482,420
-12,900
-3% -$1.15M 0.07% 286
2018
Q4
$39.4M Buy
495,320
+65,200
+15% +$6.09M 0.08% 259
2018
Q3
$36.4M Buy
430,120
+2,000
+0.5% +$185K 0.06% 290
2018
Q2
$31.4M Sell
428,120
-50,400
-11% -$4.21M 0.06% 303
2018
Q1
$31.2M Sell
478,520
-5,700
-1% -$470K 0.06% 307
2017
Q4
$32.6M Buy
484,220
+4,943
+1% +$396K 0.06% 309
2017
Q3
$37.3M Sell
479,277
-873,600
-65% -$72.5M 0.06% 317
2017
Q2
$120M Sell
1,352,877
-513,961
-28% -$43.3M 0.22% 142
2017
Q1
$150M Sell
1,866,838
-578,285
-24% -$45.2M 0.28% 105
2016
Q4
$165M Sell
2,445,123
-172,600
-7% -$13.6M 0.31% 78
2016
Q3
$226M Buy
2,617,723
+820,800
+46% +$71.5M 0.4% 54
2016
Q2
$156M Buy
1,796,923
+143,000
+9% +$11.6M 0.29% 101
2016
Q1
$124M Sell
1,653,923
-308,077
-16% -$23.2M 0.26% 112
2015
Q4
$151M Sell
1,962,000
-167,115
-8% -$12.6M 0.35% 78
2015
Q3
$143M Sell
2,129,115
-125,360
-6% -$9.23M 0.33% 88
2015
Q2
$167M Buy
2,254,475
+250,028
+12% +$19.1M 0.34% 79
2015
Q1
$156M Buy
2,004,447
+278,174
+16% +$21.1M 0.32% 87
2014
Q4
$125M Buy
1,726,273
+57,120
+3% +$3.97M 0.24% 118
2014
Q3
$103M Buy
1,669,153
+16,774
+1% +$1.07M 0.21% 130
2014
Q2
$105M Buy
1,652,379
+119,882
+8% +$7.28M 0.22% 121
2014
Q1
$94.3M Buy
1,532,497
+306,633
+25% +$17.9M 0.25% 112
2013
Q4
$70.4M Buy
1,225,864
+11,143
+0.9% +$632K 0.21% 142
2013
Q3
$64.7M Sell
1,214,721
-238,331
-16% -$12.8M 0.2% 147
2013
Q2
$74.8M Buy
+1,453,052
New +$71.8M 0.23% 126

Other funds holding MDT

APG Asset Management's MDT Position: Q2 2026 in Review

APG Asset Management increased its Medtronic (MDT) stake by 36% in Q2 2026, buying an estimated $19.7M and bringing the position to 921,755 shares worth $63.1M. The position accounts for 0.15% of the portfolio, ranked #125.

APG Asset Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $226M in Q3 2016. 1,806 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • APG Asset Management held 921,755 shares of Medtronic worth $63.1M as of Q2 2026.
  • APG Asset Management bought 244,227 Medtronic shares in Q2 2026, an estimated $19.7M.
  • Medtronic made up 0.15% of APG Asset Management's portfolio in Q2 2026, its #125 holding.
  • APG Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • APG Asset Management's Medtronic position peaked at $226M in Q3 2016.
  • 1,806 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on APG Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.